Oxford, AstraZeneca to resume Covid-19 vaccine trial after UK patient's illness
Oxford University says trials of a coronavirus vaccine that it is developing with pharmaceutical company AstraZeneca will resume, days after being paused due to a reported side-effect in a patient in the U.K.Sat, 12 Sep 2020 15:02:10 GMTNEWS WIRES
0 Response to "Oxford, AstraZeneca to resume Covid-19 vaccine trial after UK patient's illness"
Post a Comment